Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Drugs for Central Nervous System Diseases market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Central Nervous System Diseasesmarket, defines the market attractiveness level of Drugs for Central Nervous System Diseases market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Drugs for Central Nervous System Diseases industry, describes the types of Drugs for Central Nervous System Diseases market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Central Nervous System Diseases market and the development prospects and opportunities of Drugs for Central Nervous System Diseases industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Central Nervous System Diseases market in Chapter 13.
By Player:
Merck
Lilly
Astrazeneca
GSK
Pfizer
Sunovion Pharmaceuticals
Biogen
Bristol Myers Squibb
Norvatis
Alkermes
Teva
By Type:
Antidepressants
Anxiolytics
Anti-manic
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Drugs for Central Nervous System Diseases Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Drugs for Central Nervous System Diseases Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Drugs for Central Nervous System Diseases Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Drugs for Central Nervous System Diseases Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Drugs for Central Nervous System Diseases Market Analysis and Outlook to 2022
-
7.1 Global Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.2 United States Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.3 Europe Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.4 China Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.5 Japan Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.6 India Drugs for Central Nervous System Diseases Consumption (2017-2022)
-
7.7 South Korea Drugs for Central Nervous System Diseases Consumption (2017-2022)
8 Region and Country-wise Drugs for Central Nervous System Diseases Market Analysis and Outlook to 2028
-
8.1 Global Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.2 United States Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.3 Europe Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.4 China Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.5 Japan Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.6 India Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
-
8.7 South Korea Drugs for Central Nervous System Diseases Consumption Forecast (2022-2028)
9 Global Drugs for Central Nervous System Diseases Market Outlook by Types and Applications to 2022
-
9.1 Global Drugs for Central Nervous System Diseases Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antidepressants Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anxiolytics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Anti-manic Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Drugs for Central Nervous System Diseases Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Drugs for Central Nervous System Diseases Market Outlook by Types and Applications to 2028
-
10.1 Global Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anxiolytics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Anti-manic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Drugs for Central Nervous System Diseases Import and Export Analysis (Top 5 Countries)
-
11.1 Global Drugs for Central Nervous System Diseases Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Drugs for Central Nervous System Diseases Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Drugs for Central Nervous System Diseases Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Drugs for Central Nervous System Diseases Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Drugs for Central Nervous System Diseases Product and Service
-
14.2 Lilly
-
14.2.1 Lilly Company Details
-
14.2.2 Lilly Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Lilly Drugs for Central Nervous System Diseases Product and Service
-
14.3 Astrazeneca
-
14.3.1 Astrazeneca Company Details
-
14.3.2 Astrazeneca Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astrazeneca Drugs for Central Nervous System Diseases Product and Service
-
14.4 GSK
-
14.4.1 GSK Company Details
-
14.4.2 GSK Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GSK Drugs for Central Nervous System Diseases Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Drugs for Central Nervous System Diseases Product and Service
-
14.6 Sunovion Pharmaceuticals
-
14.6.1 Sunovion Pharmaceuticals Company Details
-
14.6.2 Sunovion Pharmaceuticals Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sunovion Pharmaceuticals Drugs for Central Nervous System Diseases Product and Service
-
14.7 Biogen
-
14.7.1 Biogen Company Details
-
14.7.2 Biogen Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biogen Drugs for Central Nervous System Diseases Product and Service
-
14.8 Bristol Myers Squibb
-
14.8.1 Bristol Myers Squibb Company Details
-
14.8.2 Bristol Myers Squibb Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol Myers Squibb Drugs for Central Nervous System Diseases Product and Service
-
14.9 Norvatis
-
14.9.1 Norvatis Company Details
-
14.9.2 Norvatis Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Norvatis Drugs for Central Nervous System Diseases Product and Service
-
14.10 Alkermes
-
14.10.1 Alkermes Company Details
-
14.10.2 Alkermes Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Alkermes Drugs for Central Nervous System Diseases Product and Service
-
14.11 Teva
-
14.11.1 Teva Company Details
-
14.11.2 Teva Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Teva Drugs for Central Nervous System Diseases Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Drugs for Central Nervous System Diseases
-
Figure Drugs for Central Nervous System Diseases Picture
-
Table Global Drugs for Central Nervous System Diseases Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Central Nervous System Diseases Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Drugs for Central Nervous System Diseases Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Drugs for Central Nervous System Diseases Consumption by Country (2017-2022)
-
Figure United States Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Table Europe Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Figure China Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Figure Japan Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Figure India Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Figure South Korea Drugs for Central Nervous System Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs for Central Nervous System Diseases Consumption Forecast by Country (2022-2028)
-
Figure United States Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Drugs for Central Nervous System Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Anxiolytics Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-manic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anxiolytics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-manic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Drugs for Central Nervous System Diseases Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Drugs for Central Nervous System Diseases Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Drugs for Central Nervous System Diseases Product and Service
-
Table Lilly (Foundation Year, Company Profile and etc.)
-
Table Lilly Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Drugs for Central Nervous System Diseases Product and Service
-
Table Astrazeneca (Foundation Year, Company Profile and etc.)
-
Table Astrazeneca Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astrazeneca Drugs for Central Nervous System Diseases Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Drugs for Central Nervous System Diseases Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Drugs for Central Nervous System Diseases Product and Service
-
Table Sunovion Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunovion Pharmaceuticals Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunovion Pharmaceuticals Drugs for Central Nervous System Diseases Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Drugs for Central Nervous System Diseases Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Drugs for Central Nervous System Diseases Product and Service
-
Table Norvatis (Foundation Year, Company Profile and etc.)
-
Table Norvatis Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Norvatis Drugs for Central Nervous System Diseases Product and Service
-
Table Alkermes (Foundation Year, Company Profile and etc.)
-
Table Alkermes Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkermes Drugs for Central Nervous System Diseases Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Drugs for Central Nervous System Diseases Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Drugs for Central Nervous System Diseases Product and Service
-
